Stonebridge Financial Planning Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-750
Closed -$61K 267
2021
Q4
$61K Hold
750
0.03% 199
2021
Q3
$67K Hold
750
0.03% 193
2021
Q2
$58K Sell
750
-560
-43% -$41.7K 0.03% 198
2021
Q1
$95K Sell
1,310
-105
-7% -$7.75K 0.06% 165
2020
Q4
$110K Hold
1,415
0.07% 143
2020
Q3
$108K Hold
1,415
0.08% 127
2020
Q2
$106K Hold
1,415
0.09% 124
2020
Q1
$110K Sell
1,415
-43
-3% -$3.38K 0.11% 114
2019
Q4
$127K Buy
+1,458
New +$120K 0.11% 114

Other funds holding MRK

Stonebridge Financial Planning Group's MRK Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of Merck (MRK) in Q1 2022, closing a stake of 750 shares — an estimated $61K sold.

Stonebridge Financial Planning Group first reported a position in MRK in Q4 2019 and held it in 9 quarters. The position peaked at $127K in Q4 2019. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Stonebridge Financial Planning Group reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 750 Merck shares in Q1 2022, an estimated $61K.
  • Stonebridge Financial Planning Group first reported a position in Merck in Q4 2019 and held it in 9 quarters.
  • Stonebridge Financial Planning Group's Merck position peaked at $127K in Q4 2019.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.